Michela Cesco-Gaspere

Author PubWeight™ 9.13^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Monoclonal T-cell receptors: new reagents for cancer therapy.	Mol Ther	2007	1.34
2	Targeting the Wilms tumor antigen 1 by TCR gene transfer: TCR variants improve tetramer binding but not the function of gene modified human T cells.	J Immunol	2007	1.15
3	Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulins.	Front Oncol	2012	0.92
4	Membrane IgE binds and activates Fc epsilon RI in an antigen-independent manner.	J Immunol	2005	0.88
5	WT1-specific T cell receptor gene therapy: improving TCR function in transduced T cells.	Blood Cells Mol Dis	2007	0.85
6	Efficient folding of the FcepsilonRI alpha-chain membrane-proximal domain D2 depends on the presence of the N-terminal domain D1.	J Mol Biol	2002	0.84
7	T-cell receptor gene therapy for cancer: the progress to date and future objectives.	Expert Opin Biol Ther	2007	0.82
8	A minimal receptor-Ig chimera of human FcepsilonRI alpha-chain efficiently binds secretory and membrane IgE.	Protein Eng	2002	0.79
9	Gangliosides, Ab1 and Ab2 antibodies III. The idiotype of anti-ganglioside mAb P3 is immunogenic in a T cell-dependent manner.	Mol Immunol	2007	0.79
10	Anti-idiotypic DNA vaccines for B-cell lymphoma therapy.	Front Biosci	2002	0.76